PPT-Impella

Author : yoshiko-marsland | Published Date : 2016-03-20

Technology Emergent Support Clinical Evidence and Investigations The Current Use of Impella 25 in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Impella" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Impella: Transcript

Technology Emergent Support Clinical Evidence and Investigations The Current Use of Impella 25 in Acute Myocardial Infarction Complicated by Cardiogenic Shock Results from the USpella Registry. Technology. Elective . Support. Clinical . Evidence and . Investigations. PROTECT II. O’Neill et al, . Circulation. 2012;126(14):1717-27. . PROTECT II Trial Design. IMPELLA 2.5 . +. PCI. IABP + . Main Projects:. 14 Fr Unable to Pass . 23 Fr 2 Year Aging. 23 Fr New Valve Design. 14 Fr Introducer – Unable to . Pass Overview . of Issue. . 3. Design Requires 14Fr Tip to expand to accommodate CP. Case based algorithm. Jayant Bagai, MD, FACC, FSCAI. Vanderbilt University Medical Center. VA Tennessee Valley Healthcare System. Nashville, TN. Disclosures. I have no conflicts of interest to disclose with regards to this presentation. A New Way to Treat LeftHeart Failure A Guide for Families and Caregivers Impella Support System Patient Brochure Page 2 of 17 About This Booklet his booklet is for people like you whohave a family William W. O’Neill, MD. Henry Ford Health System. Medical Director. Center for Structural Heart Disease. Detroit, MI. Diffuse Multivessel. Disease. . Border Zone. Dysfunction. Central Zone. Dyskinesis. Farhan J. Khawaja MD, FACC, FSCAI, RPVI. OUTLINE. Definition of Cardiogenic Shock. Epidemiology- A Call to Action. Treatment of Cardiogenic Shock . Advances . in the Treatment of Cardiogenic Shock. . DR. SUVANKAR GHOSH. BANKERS HEART INSTITUTE AND RESEARCH CENTRE. Physiology . Myocardial Oxygen Supply and Demand. a,b. Goals of Hemodynamic Support During High-Risk PCI. Types of Hemodynamic Support in the . Impella. 5.5 with . SmartAssist. ®:. Overview. Microaxial. blood pump. Implanted via axillary or trans-aortic approach with surgical . cath. hybrid procedure. Can unload up to 6 LPM from LV. Cannula 21 . EO O’Brien. Department of . Anesthesilogy. UCSD. Case Presentation. 64 M with a PMH s/f AHA Class D CHF (EF < 20%) on inotropic support on the floor was 5 days post-op from placement of an . Impella.

Download Document

Here is the link to download the presentation.
"Impella"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.